Inventor · disambiguated record
Karl Richard Gibson
Also filed as: GIBSON KARL · GIBSON KARL RICHARD
27 granted patents·17 pending applications·101 citations·filing 1999–2025
95Inventor score
Files withMISSION THERAPEUTICS LTD13CENTESSA PHARMACEUTICALS UK LTD4GIBSON KARL RICHARD3PFIZER LTD3UNIV SHEFFIELD3
Top patents by PatentIndex Score
44 records- 0194US9926307B2CompoundsMISSION THERAPEUTICS LTD·Filed 2015·Granted Mar 27, 2018·14 cites·16 claims
- 0293US10343992B21-cyano-pyrrolidine compounds as USP30 inhibitorsMISSION THERAPEUTICS LTD·Filed 2016·Granted Jul 9, 2019·7 cites·2 claims
- 0392US10689345B21-cyano-pyrrolidine compounds as USP30 inhibitorsMISSION THERAPEUTICS LTD·Filed 2019·Granted Jun 23, 2020·4 cites·14 claims
- 0489US10392380B2CompoundsMISSION THERAPEUTICS LTD·Filed 2018·Granted Aug 27, 2019·6 cites·17 claims
- 0587US10774078B2CompoundsMISSION THERAPEUTICS LTD·Filed 2019·Granted Sep 15, 2020·2 cites·10 claims
- 0687US8846698B2Pyrrolo[2,3-d]pyrimidine tropomysin-related kinase inhibitorsANDREWS MARK DAVID·Filed 2012·Granted Sep 30, 2014·15 cites·35 claims
- 0786US11472798B2CompoundsMISSION THERAPEUTICS LTD·Filed 2020·Granted Oct 18, 2022·1 cites·11 claims
- 0885US10640498B2CompoundsMISSION THERAPEUTICS LTD·Filed 2017·Granted May 5, 2020·6 cites·17 claims
- 0983US11390584B21-cyano-pyrrolidine compounds as USP30 inhibitorsMISSION THERAPEUTICS LTD·Filed 2020·Granted Jul 19, 2022·1 cites·14 claims
- 1081US11993595B2CompoundsMISSION THERAPEUTICS LTD·Filed 2022·Granted May 28, 2024·0 cites·10 claims
- 1179US9273011B2Substituted pyridazines for the treatment of painINHIBITAXIN LTD·Filed 2012·Granted Mar 1, 2016·6 cites·20 claims
- 1279US7572797B2Amino substituted pyrazine derivatives for the treatment of painPFIZER·Filed 2006·Granted Aug 11, 2009·6 cites·10 claims
- 1378US8134007B2Pyridine derivativesBAGAL SHARANJEET KAUR·Filed 2008·Granted Mar 13, 2012·8 cites·23 claims
- 1478US2022251041A11-cyano-pyrrolidine compounds as usp30 inhibitorsMISSION THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1574US2025236629A1Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and related usesCENTESSA PHARMACEUTICALS UK LTD·Filed 2024·Application pending·0 cites
- 1672US10683269B22-cyanoisoindoline derivatives for treating cancerMISSION THERAPEUTICS LTD·Filed 2017·Granted Jun 16, 2020·1 cites·15 claims
- 1770US11066365B21-cyano-pyrrolidine compounds as USP30 inhibitorsMISSION THERAPEUTICS LTD·Filed 2019·Granted Jul 20, 2021·0 cites·14 claims
- 1870US11053198B21-cyano-pyrrolidine compounds as USP30 inhibitorsMISSION THERAPEUTICS LTD·Filed 2019·Granted Jul 6, 2021·0 cites·4 claims
- 1970US9163021B2Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitorsPFIZER LTD·Filed 2013·Granted Oct 20, 2015·2 cites·10 claims
- 2067US2025100968A1Bicyclic-heterocycle derivatives and related usesCENTESSA PHARMACEUTICALS UK LTD·Filed 2024·Application pending·0 cites
- 2164US6337331B1Triazolo-pyrimidine as ligands for GABA receptorsMERCK SHARP & DOHME·Filed 1999·Granted Jan 8, 2002·21 cites·10 claims
- 2263US9447116B2Inhibitors of HIV replicationVIIV HEALTHCARE UK LTD·Filed 2014·Granted Sep 20, 2016·0 cites·2 claims
- 2363US2025289828A1Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and related usesCENTESSA PHARMACEUTICALS UK LTD·Filed 2025·Application pending·0 cites
- 2460US8809363B2Inhibitors of HIV replicationBELL ANDREW SIMON·Filed 2011·Granted Aug 19, 2014·0 cites·3 claims
- 2558US8232269B2Amide compounds useful in therapyGIBSON KARL RICHARD·Filed 2009·Granted Jul 31, 2012·1 cites·23 claims
- 2658US2022169653A1Pyrrolopyrimidine and pyrrolopyridine derivativesGALAPAGOS NV·Filed 2021·Application pending·0 cites
- 2758US2024239744A12-(3-ethynylbenzyl)-substituted heterocycle derivatives and related usesOREXIA THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 2857US7410964B2Cyclohexyl sulphones as gamma-secretase inhibitorsMERCK SHARP & DOHME·Filed 2004·Granted Aug 12, 2008·0 cites·4 claims
- 2955US2023331720A1Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and their uses as orexin-2 receptor agonistsOREXIA THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 3053US2016355528A1Inhibitors of hiv replicationVIIV HEALTHCARE UK LTD·Filed 2016·Application pending·0 cites
- 3152US12503475B2Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonistsCENTESSA PHARMACEUTICALS UK LTD·Filed 2021·Granted Dec 23, 2025·0 cites·20 claims
- 3252US11136325B2Pyrrolopyrimidine and pyrrolopyridine derivativesGALAPAGOS NV·Filed 2018·Granted Oct 5, 2021·0 cites·14 claims
- 3352US2014364415A1PYRROLO[2,3-d]PYRIMIDINE TROPOMYSIN-RELATED KINASE INHIBITORSPFIZER LTD·Filed 2014·Application pending·0 cites
- 3444US2010240652A1Pyridine Derivatives as Sodium Channel ModulatorsPFIZER·Filed 2007·Application pending·0 cites
- 3543US11400081B2CompoundsUNIV SHEFFIELD·Filed 2018·Granted Aug 2, 2022·0 cites·21 claims
- 3643US2005038047A1Azaquinazoline derivativesFiled 2004·Application pending·0 cites
- 3742US10016420B2Substituted pyridazines for the treatment of painINHIBITAXIN LTD·Filed 2016·Granted Jul 10, 2018·0 cites·9 claims
- 3841US2015218172A1Pyrrolo[2,3-D]Pyrimidine Tropomyosin-Related Kinase InhibitorsPFIZER LTD·Filed 2013·Application pending·0 cites
- 3941US2022023281A1Heterocyclic spiro-compounds as am2 receptor inhibitorsUNIV SHEFFIELD·Filed 2019·Application pending·0 cites
- 4041US2008096950A1Compounds Useful In TherapyGIBSON KARL RICHARD·Filed 2007·Application pending·0 cites
- 4141US2023036854A1Heterocyclic spiro-compounds as am2 receptor inhibitorsUNIV SHEFFIELD·Filed 2019·Application pending·0 cites
- 4240US11660293B2Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives as orexin receptor antagonistsCHRONOS THERAPEUTICS LTD·Filed 2018·Granted May 30, 2023·0 cites·20 claims
- 4335US2001053776A1Tricyclic pyridin-2-one analogue as a GABA receptor ligandFiled 2001·Application pending·0 cites
- 4433US2012316150A1Amide compounds useful in therapyGIBSON KARL RICHARD·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Karl Richard Gibson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →